Table 2.
Comparison of age at diagnosis of hematological malignancies with age-based exclusion
| Diagnoses | On-going clinical trials |
SEER dataa |
||
|---|---|---|---|---|
| Patients aged 65+ years excluded (%) | Patients aged 70+ years excluded (%) | Median age at diagnosis (years) | % older than 65 years at diagnosis | |
| Acute lymphocytic leukemia | 57 | 63 | 14 | 10.8 |
| Hodgkin lymphoma | 33 | 39 | 38 | 17.7 |
| Chronic myeloid leukemia | 11 | 17 | 64 | 48.8 |
| Non-Hodgkin lymphoma | 3 | 12 | 66 | 54.4 |
| Acute myeloid leukemia | 26 | 35 | 67 | 54.1 |
| Multiple myeloma | 7 | 14 | 69 | 62.4 |
| Myelodysplastic syndrome | 2 | 8 | 70 | 80.0 |
| Chronic lymphocytic leukemia | 1 | 3 | 71 | 68.1 |
aThe SEER (Surveillance Epidemiology and End-Results) program collects information on incidence, prevalence and survival from specific geographic areas representing 28 percent of the United States population.